Therapy Areas: Vaccines
Research Center of America announces recruitment of healthy workers for COVID-19 research clinical trial in the fight against the virus
5 August 2020 -

Research company Research Centers of America (RCA) said on Tuesday that it is recruiting volunteers to participate in the clinical investigations of COVID-19 vaccines by several big companies under Operation Warp Speed, the Federal Government protocol and US FDA.

The RCA's medical director Dr Howard Schwartz participated in a conference with vice president Mike Pence, school leaders and members of the Miller School of Medicine, along with several other researchers working together to end the battle against COVID-19.

RCA will recruit between 300 and 500 participants solely for the Moderna study, under which, approximately 30,000 participants are expected to enroll in the US. The randomized, placebo-controlled study is expected to investigate a mRNA-1273 dose of 100 µg. The primary objective will be prevention of symptomatic COVID-19 disease.

To ensure the safety and ongoing monitoring of study participants, the data will be reviewed by an independent Data and Safety Monitoring Board organized by NIAID throughout the study, concluded RCA.

Login
Username:

Password: